We found Rel expression upregulated 2.736-fold in B-CLL, 4.039-fold in B-cell NHL, 65.526-fold in AML, and 6.912-fold in HCL cases. The gene discussed is REL; the disease is B-cell non-Hodgkin lymphoma.